%D9%85%D8%B1%D8%B6_%D8%A7%D9%84%D8%AA%D9%83%D8%A7%D8%AB%D8%B1_%D8%A7%D9%84%D9%84%D9%8A%D9%85%D9%81%D8%A7%D9%88%D9%8AAutoimmune_lymphoproliferative_syndromeS%C3%ADndrome_linfoproliferativo_autoinmuneSyndrome_lymphoprolif%C3%A9ratif_avec_auto-immunit%C3%A9Sindrom_limfoproliferatif_autoimunAuto-immuun_lymfoproliferatief_syndroomQ1151300
about
Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)Sirolimus for Autoimmune Disease of Blood CellsFluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated LymphomaPyrimethamine to Treat Autoimmune Lymphoproliferative SyndromePyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative SyndromeStudy of Autoimmune Lymphoproliferative Syndrome (ALPS)Immune Disorder HSCT ProtocolFluorodeoxyglucose Imaging Studies to Detect Lymphoma
P1050
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type IIUsing biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndromeAdvances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International WorkshopHow I treat autoimmune lymphoproliferative syndromeUse of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndromeRapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS)Autoimmune lymphoproliferative syndrome: a case report and literature reviewApproaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative SyndromeAutoimmune lymphoproliferative syndrome: an update and review of the literatureAutoimmune Lymphoproliferative SyndromeAutoimmune lymphoproliferative syndromeReversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observationsA composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndromeFAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndromePyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndromeA survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutationUse of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndromeRapid regression of lymphadenopathy upon rapamycin treatment in a child with autoimmune lymphoproliferative syndromeDevelopment of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutationsThe autoimmune lymphoproliferative syndrome: an experiment of nature involving lymphocyte apoptosisIdentifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional studyAutoimmune lymphoproliferative syndrome with somatic Fas mutationsUnmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS)Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosisCauses and consequences of the autoimmune lymphoproliferative syndromeFAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of functionAutoimmune lymphoproliferative syndrome: new approaches to diagnosis and managementCo-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndromeDominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type IbAn inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.Description of serologic features in autoimmune lymphoproliferative syndrome.RBC autoantibodies in autoimmune lymphoproliferative syndrome.Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome.FAS gene mutation in a case of autoimmune lymphoproliferative syndrome type IA with accumulation of gammadelta+ T cells.Mycophenolate mofetil as an alternate immunosuppressor for autoimmune lymphoproliferative syndrome.Autoimmune lymphoproliferative syndrome (ALPS): a case with congenital onset.Rituximab responsive immune thrombocytopenic purpura in an adult with underlying autoimmune lymphoproliferative syndrome due to a splice-site mutation (IVS7+2 T>C) affecting the Fas gene.
P921
Q64725151-5E30C187-2294-4A73-8E76-2B6F28A940E2Q65386378-CE174B84-62D6-4B9B-BD5B-9F35E78F9332Q66034943-FEA0E521-F9FE-4BD8-B954-476290D8070AQ66035460-F61448A5-5792-4015-88E8-070F0CC698B8Q66059675-4A0F8668-5032-4E95-9E40-AF254645E012Q66061335-DF7F0E1C-8129-41BA-B7A2-60635437B203Q66344455-02AF7EEE-C9C4-4883-98F1-98CC4548E634Q66346840-C9164BB2-743E-4E29-B0FB-FDAE9CA06CD0
P1050
Q22010404-C316F5C3-60C9-4204-93EA-2BC6C15B19FFQ24623046-77E292D8-F514-448F-A163-36EFA19C64A5Q24623371-68D021E0-8995-4A47-9250-D04F46CCE2C4Q24632569-877141DE-AB17-49A5-9B78-2F68293C9C5CQ24633207-9620999A-19D6-4956-8507-524BA9F6EFA9Q24643047-3DF28FC8-3497-4D0B-8CD8-09FCC03C8B8BQ24650472-668DCACA-22B7-446C-98AD-AA8A58F87DF1Q24685850-3D47E000-F5EC-4AC0-8DF5-7BD67A50D99AQ26775016-5AA9FC0A-FFA0-4CD7-B827-943CEC304065Q26799956-A7054BF9-43FA-4351-A3CD-4854FCABF179Q26825740-496F3119-73E6-4710-AE0E-F18EC1A5B07EQ26830655-DA91E7ED-BF87-4996-81EA-DBA5AA68E440Q28181118-196576E2-FF51-4972-A194-1B0B71F9449CQ28210645-1B7F86CE-D55B-457A-984C-50CF4A760D22Q28215936-3D82C241-5BE7-4A21-B907-D03A5B3D7DB6Q28235519-A4A96B01-BA7E-4A3E-BCCE-F76E1396918EQ28239313-F6CB32C2-EABB-485B-BEBC-64C0C30E79E7Q28246980-8E88CBAB-D7E1-4AF4-A944-BA5E542ADE6FQ28248908-2F74E93E-F844-47A8-BCCD-ADD1D7659A28Q28251352-6B1BB9A1-5D65-4429-B949-1A7C5064E88EQ28263161-401A6011-952C-4C75-BDDB-8FB5CD209C09Q28264600-E666ED0C-33F6-4595-BD6B-451325BE8A0FQ28270195-E3B21608-42E2-4B5A-9B40-A42478A0BCB7Q28285625-346DC17A-6ED1-4773-84ED-89D9BC161BAAQ28293136-4515E760-80BC-472A-B621-E904F0045B3CQ28299956-236254FC-98CF-412C-9A40-F65988C7E526Q28300792-E7DFF543-3E84-4F07-9598-E1311BD01154Q28307801-6F1D3361-80E2-476F-9058-A84A8998F84CQ28308285-B3B30843-ED54-45B4-B605-9AB5DF14A80FQ30838565-F27ABE51-6F31-4136-BCF2-A474C5535B38Q33289658-F0555E46-A66C-4861-A37A-C0ABE97D938EQ33328425-68A1FEEF-9C86-4954-BE9F-EC43B6D4AE39Q33330741-CF00758B-C241-462D-9B4B-5F8D18BABC5DQ33333768-207379B0-A55A-4D2C-97CE-71A983673B78Q33335780-EE13B963-F882-4C29-AB92-6A37DF90004FQ33343951-43B58240-3E97-4F24-8DA5-815E80BBA2F4Q33347162-477ED7B7-766C-4FD9-8759-856E4B76C2DDQ33373569-A54F4F98-97F3-43FC-A910-B2F7CF4CACF4Q33375938-5C573189-7AD2-4382-9936-BB90215E96B1Q33376403-D7B862C8-9274-4927-9BE0-FCD17C379621
P921
description
Human disease
@en
Krankheit
@de
مرض يصيب الإنسان
@ar
name
Auto-immuun lymfoproliferatief syndroom
@nl
Sindrom limfoproliferatif autoimun
@id
Syndrome lymphoprolifératif avec auto-immunité
@fr
Síndrome linfoproliferativo autoinmune
@es
autoimmune lymphoproliferative syndrome
@en
مرض التكاثر الليمفاوي
@ar
自己免疫性リンパ増殖症候群
@ja
type
label
Auto-immuun lymfoproliferatief syndroom
@nl
Sindrom limfoproliferatif autoimun
@id
Syndrome lymphoprolifératif avec auto-immunité
@fr
Síndrome linfoproliferativo autoinmune
@es
autoimmune lymphoproliferative syndrome
@en
مرض التكاثر الليمفاوي
@ar
自己免疫性リンパ増殖症候群
@ja
altLabel
ALPS (autoimmune lymphoproliferative syndrome)
@en
ALPS
@en
Canale-Smith syndrome
@en
Sindrome linfoproliferativo autoinmune
@es
type 1b ALPS
@en
type 2 ALPS
@en
自己免疫リンパ増殖症候群
@ja
prefLabel
Auto-immuun lymfoproliferatief syndroom
@nl
Sindrom limfoproliferatif autoimun
@id
Syndrome lymphoprolifératif avec auto-immunité
@fr
Síndrome linfoproliferativo autoinmune
@es
autoimmune lymphoproliferative syndrome
@en
مرض التكاثر الليمفاوي
@ar
自己免疫性リンパ増殖症候群
@ja
P2888
P672
P486
P6366
P646
P1692
P1748
P1995
P2892
P4229
P486
P492
P6366
2778959938
P646
/m/03qcbmd
P672
C15.604.515.138
C16.320.089
C20.111.288
C20.683.515.124